Plasma Chromogranin B as a Marker of Tumor Burden and Radiological Progression in Neuroendocrine Tumors

被引：0
|
作者：
Braude, D. [1 ]
Bartholomew, T. K. [1 ]
Rossi, R. E. [1 ]
Garcia-Hernandez, A. [1 ]
Mullan, M. [1 ]
Caplin, M. [1 ]
Toumpanakis, C. [1 ]
机构：
[1] Royal Free Hosp, ENETS Ctr Excellence, Neuroendocrine Tumour Unit, London NW3 2QG, England
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
chromogranin b; midgut nets; pancreatic net; progression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H3
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [31] Utility of Serum Chromogranin B Compared with Chromogranin A as a Biomarker in Japanese Patients with Pancreatic Neuroendocrine Tumors
    Miki, M.
    Ito, T.
    Hijioka, M.
    Kawabe, K.
    Jensen, R. T.
    NEUROENDOCRINOLOGY, 2017, 105 : 157 - 157
  • [32] Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease Progression
    Ramachandran, R.
    Bech, P.
    Murphy, K. G.
    Caplin, M. E.
    Patel, M.
    Vohra, S.
    Khan, M. S.
    Dhillo, W. S.
    Sharma, R.
    Palazzo, F. F.
    Win, Z.
    Tan, T.
    Khoo, B.
    Meeran, K.
    Frilling, A.
    Ghatei, M. A.
    Bloom, S. R.
    Martin, N. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04): : 1520 - 1528
  • [33] Adrenomedullin is a novel marker of tumor progression in neuroendocrine carcinomas
    Pavel, ME
    Hoppe, S
    Papadopoulos, T
    Linder, V
    Mohr, B
    Hahn, EG
    Lohmann, T
    Schuppan, D
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (02) : 112 - 118
  • [34] Chromogranin A as a Tumoral Marker for Neuroendocrine Tumors in Chilean Patients: A Case-Control Study
    Munoz-Medel, M.
    Cordova Delgado, M.
    Pinto, M.
    Bravo, M. L.
    Retamal, I
    Carrillo, D.
    Garrido, M.
    NEUROENDOCRINOLOGY, 2020, 110 : 148 - 148
  • [35] Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress
    Touitou, Yvan
    Lambrozo, Jacques
    Mauvieux, Benoit
    Riedel, Marc
    CHRONOBIOLOGY INTERNATIONAL, 2020, 37 (01) : 60 - 67
  • [36] Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors
    Arnold, Rudolf
    Wilke, Alexandra
    Rinke, Anja
    Mayer, Christina
    Kann, Peter Herbert
    Klose, Klaus-Jochen
    Scherag, Andre
    Hahmann, Maik
    Mueller, Hans-Helge
    Barth, Peter
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (07) : 820 - 827
  • [37] Serum Chromogranin A is a Predictor for Liver Metastatic Tumor Burden and Therapeutic Response in Advanced Non-Functional Pancreatic Neuroendocrine Tumors
    Zhang, C.
    Han, X.
    Tang, M.
    Ji, Y.
    Pan, B.
    Lou, W.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 258 - 259
  • [38] Primary Cilia as a Tumor Marker in Pituitary Neuroendocrine Tumors
    Martinez-Hernandez, Rebeca
    Serrano-Somavilla, Ana
    Fernandez-Contreras, Raul
    Sanchez-Guerrero, Cristina
    de la Blanca, Nuria Sanchez
    Sacristan-Gomez, Pablo
    Sebastian-Valles, Fernando
    Sampedro-Nunez, Miguel
    Fraga, Javier
    Calatayud, Maria
    Vicente, Almudena
    Garcia-de-Casasola, Gonzalo
    Sanz-Garcia, Ancor
    Araujo-Castro, Marta
    Ruz-Caracuel, Ignacio
    Puig-Domingo, Manel
    Marazuela, Monica
    MODERN PATHOLOGY, 2024, 37 (05)
  • [39] Role of plasma octreotide and chromogranin A (CGA) level in the management of neuroendocrine tumors (NET)
    Go, Vay Liang W.
    Mamikunian, Gregg
    O'Dorisio, Thomas M.
    Vinik, Aaron I.
    Woltering, Eugene A.
    REGULATORY PEPTIDES, 2006, 135 (03) : 126 - 127
  • [40] Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum Discussion
    Townsend, Courtney M.
    Evers, Mark
    Levine, Edward
    Meyers, Michael
    Perrier, Nancy
    Boudreaux, Philip
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 542 - 544
12345